My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Gilead Sciences (NQ:GILD)

151.40 +0.28 (+0.19%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Gilead Sciences

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

51 52 Next >

Biotech Sector: On The Verge Of Triumph Or Turmoil? ↗

October 06, 2023

In this article, we delve into the Biotech Sector, exploring its promises, potential pitfalls, and the questions that arise.

Via Talk Markets

Here's How Much $100 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today ↗

October 05, 2023

Via Benzinga

Pharma Giants Combine Forces to Fight New M&A Rules ↗

October 04, 2023

Some of pharma's biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms.

Via The Motley Fool

Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs ↗

October 02, 2023

CAR T therapies have major advantages over traditional cancer drugs. Here are three of the best cancer drug stocks set to benefit from CAR T.

Via InvestorPlace

3 Magnificent Dividend Stocks to Buy in October ↗

September 30, 2023

These stocks come with great dividends and more.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 29, 2023

Via Benzinga

How Is The Market Feeling About Gilead Sciences? ↗

September 21, 2023

Via Benzinga

Gilead Sciences Unusual Options Activity ↗

September 20, 2023

Via Benzinga

$100 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today ↗

September 18, 2023

Via Benzinga

Two Trial Halts In A Row - Gilead Sciences Stops Late Stage COVID-19 Study ↗

September 28, 2023

Gilead Sciences Inc (NASDAQ: GILD) said it has

Via Benzinga

Gilead Sciences Adapts to Economic Shifts to Support Investor Confidence ↗

September 28, 2023

By the end of today, September 28, 2023, Gilead Sciences (NASDAQ:GILD) is set to deliver a dividend payout of $0.75 per share, equating to an annualized dividend yield of 3.96%.

Via Benzinga

Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields ↗

September 27, 2023

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

Via Benzinga

3 Bargain Stocks to Buy in a Market That's Priced for Perfection ↗

September 21, 2023

Many stocks have nosebleed valuations. But not these.

Via The Motley Fool

1 Huge Risk That Gene-Editing Stock Investors Desperately Need to Know ↗

September 19, 2023

Good medicines aren't always good business.

Via The Motley Fool

Time For Gilead Sciences-Heavy ETFs? ↗

September 12, 2023

Gilead Sciences has underperformed the broader market this year by a hefty margin.

Via Talk Markets

$1000 Invested In This Stock 20 Years Ago Would Be Worth $9,000 Today ↗

September 07, 2023

Via Benzinga

Where Gilead Sciences Stands With Analysts ↗

September 06, 2023

Via Benzinga

(GILD) - Analyzing Gilead Sciences's Short Interest ↗

September 05, 2023

Via Benzinga

Gilead's Breast Cancer Drug Shows Promise When Combined With Merck's Treatment ↗

September 11, 2023

Gilead Sciences Inc (NASDAQ: GILD) revealed early data from its open-label, Phase 2 EVOKE-02 study evaluating Trodelvy.

Via Benzinga

What You Need to Know About Hepatitis C This Recovery Month

September 08, 2023

(BPT) - Hepatitis C (HCV) is often referred to as the 'silent disease' due to silent symptoms that may not appear until years after exposure. In fact, of the more than 2 million Americans who are...

Via Brandpoint

How To Earn $500 A Month From Gilead Sciences Stock ↗

September 08, 2023

Shares of Gilead Sciences, Inc (NASDAQ: GILD) are trading higher during Friday’s trading session, bolstered by the Bank of America Securities bullish outlook on the stock.

Via Benzinga

Infectious Disease Player Vir Biotech Has Limited Near Term Upside, Analyst Downgrades ↗

September 08, 2023

BofA Securities has downgraded Vir Biotechnology Inc (NASDAQ: VIR) to Neutral from Buy with a price target of $14,

Via Benzinga

The Unexpected Reason Gilead Just Notched Its Biggest Single-Day Move In A Month ↗

September 08, 2023

Gilead shares are on the rise amid an unexpected boon for its HIV treatment business.

Via Investor's Business Daily

Gilead Sciences Shares Trade Higher After Bullish Analyst Upgrades Stock ↗

September 08, 2023

Shares of Gilead Sciences, Inc. (NASDAQ: GILD) are trading higher into Friday’s trading session after Bank of America Securities upgraded the stock, highlighting an underappreciated growth potential in...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023 ↗

September 08, 2023

Via Benzinga

Adobe To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Friday ↗

September 08, 2023

B of A Securities cut the price target for DigitalOcean Holdings, Inc. (NYSE: DOCN) from $47 to $25. B of A Securities analyst Wamsi Mohan downgraded the stock from Buy to Underperform. DigitalOcean...

Via Benzinga

3 No-Brainer Dividend Stocks to Buy in September ↗

September 02, 2023

Income investors should really like these biopharma stocks with juicy dividends.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 ↗

September 06, 2023

Via Benzinga

Nearing Retirement? These Stocks Will Pay You For Life ↗

August 29, 2023

These companies are passive income machines.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

August 28, 2023

Via Benzinga

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

51 52 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.